Demand of Antacids:

The key market driver for the increased demand of antacid usage is the rising
cases of gastrointestinal reflux disorder and acidity due to unhealthy food
habits. Apart from that in case of side effect of drugs such as NSAIDS and anti-
inflammatory patient need to take antacid. It is used for slowing heartburn, acid
indigestion, and sore stomach. It is also helpful in protecting stomach,
duodenum, and esophagus from acid in case of mild to moderate ulcer. This
product generally not required prescription. More over in this busy life people
are more incline towards self-medication, antacid is available over the counter
in pharmacies. Another reason is people aged 60 years or more is increasing at a
rate of 3% annually in the world and approximately 65% population from this
group is prone to acid reflux. This can be some reason for the rise of global
antacid demand.

The global antacid market size was 8255.13 million in 2018 and expected
CAGR for next 5 years (2020-2025) is 3.7%. The key players in this rising
demand of antacid are Sanofi, Aventis, LLC, Boehringer Ingelheim, Pfizer,
Bayer AG, AstraZeneca plc, Takeda Pharmaceutical Ltd, DR. Reddy’s.

Antacid market can be classified in different category e.g., proton pump

inhibitor, neutralizer. It is distributed through retail stores, E-pharmacies and
health centers (hospital, PHC). Among this distribution channel the highest
market share is of retail stores.

Antacid occurs in as liquid and tablets. Now a day’s consumer demand for fast
relief antacid is also a factor creating higher market demand for effervescent
formulation antacid. In addition, increase awareness regarding gastric disease
among the population also lead to rise in demand.